According to market research study published by Gen Consulting Company, the market size of the global biological safety testing sector is expected to rise by USD 14 billion with a CAGR of 16.3% by the end of 2028.
This industry report offers market estimates of the global market, followed by a detailed analysis of the segmentation, technology, application, and region. The global market data on biological safety testing can be segmented by segmentation: analytical testing, in vitro testing, in vivo testing. The analytical testing segment captured the largest share of the market in 2021. Biological safety testing market is further segmented by technology: animal–based, cell–based, in vitro kits, protein (mAb), others. The mAb segment held the largest share of the global biological safety testing market in 2021 and is anticipated to hold its share during the forecast period. Based on application, the biological safety testing market is segmented into: adventitious agents, host cell contaminant testing, product release testing, pyrogen and endotoxins testing, sterility and bioburden testing. In 2021, the product release testing segment made up the largest share of revenue generated by the biological safety testing market. On the basis of region, the biological safety testing market also can be divided into: Asia Pacific, Europe, North America, Rest of the World (RoW).
The global biological safety testing market is highly competitive. The prominent players operating in the global biological safety testing market include BioReliance Corporation, Charles River Laboratories Inc., Eurofins Scientific SE, Lonza Group AG, SGS S.A., Thermo Fisher Scientific Inc., WuXi AppTec Co. Ltd.
The data-centric report focuses on market trends, status and outlook for segments. With comprehensive market assessment across the major geographies, the report is a valuable asset for the existing players, new entrants and the future investors.
Why buy this report?
– Get a detailed picture of the Global Biological Safety Testing Market
– Identify segments/areas to invest in over the forecast period in the Global Biological Safety Testing Market
– Understand the competitive environment, the market’s leading players
– The market estimate for ease of analysis across scenarios in Excel format.
– Strategy consulting and research support for three months.
– Print authentication provided for the single-user license.
| REPORT ATTRIBUTE | DETAILS |
|---|---|
| Base Year | 2021 |
| Forecast Year | 2022-2028 |
| CAGR (2022-2028) | 16.3% |
| Pages | 21 |
| Key Players | BioReliance Corporation, Charles River Laboratories Inc., Eurofins Scientific SE, Lonza Group AG, SGS S.A., Thermo Fisher Scientific Inc., WuXi AppTec Co. Ltd. |
The global dental burs market is projected to expand at a CAGR of ~5.6 percent across the forecast period of 2024 – 2030, according to the latest edition of the…
The global urology laser market is estimated to increase at the rate of 5.6% each year in the period from 2023 to 2029. Urology lasers are medical devices specifically designed…
The global scar management market, in terms of revenue, is anticipated to progress at a CAGR of 5.8% during the forecast period, 2023-2029. Scar management encompasses various techniques and treatments…
Please fill out our form and we will get back to you.
